The Discovery of inhibitors of the SARS-CoV-2 S protein through computational drug repurposing
Description
SARS-CoV-2 must bind its principal receptor, ACE2, on the target cell to initiate infection. This interaction is largely driven by the receptor binding domain (RBD) of the viral Spike (S) protein. Accordingly, antiviral compounds that can block RBD
